Flanvotumab (Anti-TRP1 / TYRP1)
Flanvotumab (Anti-TRP1 / TYRP1) (A2309-GRP)
Products
Description
Flanvotumab (Anti-TRP1 / TYRP1) is a monoclonal antibody directed against the melanosomal membrane protein gp75 (or Tyrosinase-Related Protein 1 (TRP1)) with potential immunostimulatory and antineoplastic activities. MW: 145.5 kD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2309 |
| Target | Tyrosinase |